Építés alatt – nem éles oldal
Belépés

NCT07669389Befejeződött

Effectiveness of a Diabetes Self-Management Program Among Ethnic Minority Elderly in Rural Thailand

The Effectiveness of Diabetes Self-Management Intervention on Glycemic Control, Self-management and Psychological Distress for Ethnic Minority Elderly in Rural Areas in Thailand: A Randomized Controlled Trial

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. jún. 25.

Következő lépések

Rövid összefoglaló (regiszter, angolul)

Type 2 diabetes is a serious health condition that affects many older adults from ethnic minority communities in Northern Thailand. These populations, often referred to as hill tribes, include groups such as Akha, Lahu, Hmong, and Lisu who live in remote mountainous areas of Chiang Rai Province. Previous research has found that the prevalence of type 2 diabetes among ethnic minority elderly in Thailand is 16.8%, which is higher than the general Thai population. Many of these individuals have difficulty managing their diabetes because of low literacy, limited access to healthcare, language barriers, and poverty. The purpose of this study was to test whether a structured Diabetes Self-Management (DSM) program could help ethnic minority older adults (aged 60 years or older) improve their blood sugar control, increase their ability to manage diabetes on their own, and reduce emotional distress related to diabetes. This study used a cluster randomized controlled trial design. Villages in Chiang Rai Province were randomly assigned to either the DSM intervention group or the usual care group. A total of 108 participants (54 per group) were enrolled. Participants in the intervention group attended a 6-week education program with weekly interactive sessions covering diabetes knowledge, healthy eating, physical activity, medication management, problem solving, risk reduction, and emotional coping. Two home visits were also provided at Weeks 8 and 10. Participants in the usual care group received standard brief discharge education and routine follow-up visits. The main outcome measured was the change in HbA1c (a blood test that shows average blood sugar levels over the past 2 to 3 months) from the start of the study to 12 weeks later. Additional outcomes included changes in diabetes self-management behaviors and diabetes-related psychological distress, measured using validated questionnaires.

Állapot (regiszter)
Befejeződött
Vizsgálattípus
Beavatkozással járó
Résztvevők száma
108 (tényleges)
Első benyújtás
2026. jún. 21.
Kezdés
2025. nov. 20.
Elsődleges befejezés
2026. febr. 19.
Fő szponzor
Taipei Medical University
NCT-szám
NCT07669389

Mit vállalsz

  • Vizsgálat típusa: Beavatkozással járó
  • Bevont résztvevők: 108
  • 2025. nov. 20. és az elsődleges befejezés (2026. febr. 19.) között
  • 1 helyszín, 1 országban
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Más betegség

  • Mini-Mental State Examination (MMSE) score below 24, indicating possible cognitive impairment
  • Severe or unstable medical conditions that would preclude participation in a 6-week group education program (e.g., acute hospitalization, severe mobility limitations requiring full-time assistance)
  • Currently participating in another diabetes education or self-management intervention study

Egyéb

  • Unable to complete the informed consent process

Kiket keres a vizsgálat

  • Ethnic minority elderly aged 60 years or older residing in rural mountainous villages in Chiang Rai Province, Northern Thailand (including Akha, Lahu, Hmong, and Lisu communities)
  • Diagnosed with type 2 diabetes mellitus (T2DM) for at least one year
  • HbA1c level greater than 6.5%
  • Mini-Mental State Examination (MMSE) score of 24 or higher
  • Ability to communicate in Thai language
  • Willing and able to provide written informed consent or thumbprint with witness signature

Életkor a regiszterben: 60 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (1)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Sub-district Health Promoting Hospitals (SDHPHs), Chiang Rai ProvinceChiang RaiThaiföldIsmeretlen állapot

Te vagy a koordinátor? Erősítsd meg az adatokat

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.